In vivo modulation of antigen-experienced cells in response to high-dose oral antigen: deletion but no evidence for alterations in the cytokine phenotype-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vivo modulation of antigen-experienced cells in response to high-dose oral antigen: deletion but no evidence for alterations in the cytokine phenotype

Published:2008-05-19 Issue:7 Volume:20 Page:893-900
ISSN:1460-2377
Container-title:International Immunology
language:en
Short-container-title:

Author:

Blumenthal-Barby Friderike,Eulenburg Katharina,Schrage Arnhild,Zeitz Martin,Hamann Alf,Klugewitz Katja

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/20/7/893/17413703/dxn047.pdf

Reference32 articles.

1. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: modulation by oral administration of myelin basic protein;Popovich;J. Neuropathol. Exp. Neurol.,1997

2. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes;Ilan;Am. J. Gastroenterol.,2000

3. Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model;Ilan;Blood,2000

4. Preventive and therapeutic effects of oral tolerance in a murine model of asthma;Chung;Immunobiology,2002

5. Peripheral immune tolerance blocks clonal expansion but fails to prevent the differentiation of Th1 cells;Malvey;J. Immunol.,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged ingestion of ovalbumin diet by Ova sensitized mice suppresses mBSA-induced arthritis;Cellular Immunology;2013-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP